alphanano.tech

  • LinkedIn Social Icon

NY state has granted clinical permit to the first liquid biopsy-based ExoDx Prostate test

June 18, 2019


This is exciting news for all of the exosome researchers out there. Exosomes have been studied for about three decades now and multiple clinical applications have been proposed. One specific application was using exosomes for liquid biopsy for diagnostic purposes.

This test assists physicians in determining the need for a prostate biopsy in patients with an ambiguous prostate specific antigen (PSA) test result. It tests for three exosomal RNA biomarkers to enable physicians to assess whether a patient presenting for an initial biopsy is at greater risk for high-grade prostate cancer.

 

Source: https://www.genomeweb.com/regulatory-news/bio-techne-gets-new-york-state-approval-prostate-cancer-test#.XQkbaMhKjZs

 

 

Please reload

Featured Posts

Growing popularity of the Nanoparticle Tracking Analysis (NTA) and increasing number of service companies and academia core facilities offering Nanosi...

Quality Assurance: Nanosight Report Red Flags

July 8, 2016

1/1
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

NANO

TECH